Biogen, Inc. is a biopharmaceutical company ... and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

The signs on the city's numbered streets is part of a broader a effort to recognize the history and continued presence of ...

Cambridge Day is raising money and plans to hire a publisher, editor-in-chief, and reporters to expand the organization.

Battery tech is pivotal as the world leans into electrification to power decarbonization in the race against climate change.

At the center of a new licensing deal is an experimental medicine, PTC518, which is currently being tested in a roughly ...

Molyon has raised its first round of funding to scale a lithium-sulfur battery that delivers twice the energy density of ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...

Pour one out for hidden upstairs cocktail haven Brick & Mortar, a Central Square staple with sneakily good food—it’s closing ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. The healthcare industry remains a vital and resilient sector which is ...

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s disease. The technology ...

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. According to a Department of ...